Importantly, administration of K6PC-5 triggered a slight, but significant increase of both phospho-AKT and phospho-ERK also in iPSC-derived cortical neurons from HD patients (Fig. 10A,B and Supplementary Fig. 2). This evidence concerns the gene AKT1 and Huntington disease.